by FiveSenses | Sep 24, 2025 | News Release
Montreal, QC, Canada, September 23rd, 2025 – Defence Therapeutics Inc. (“Defence” or the “Company”), a leading biotechnology company specialized in drug delivery technologies, is pleased to share the interview of Dr. Amie Phinney, Defence’s director, strategy... 
by FiveSenses | Sep 16, 2025 | News Release
Montreal, QC, Canada, September 16th, 2025 – Defence Therapeutics Inc. (“Defence” or the “Company”), a leading biotechnology company specialized in drug delivery technologies, is pleased to announce the appointment of Dr. Amie Phinney, PhD, MBA to its Board of... by Yves Cayo | Sep 16, 2025 | News Release
Montreal, Quebec–(Newsfile Corp. – September 16, 2025) – Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) (“Defence” or the “Company”), a leading biotechnology company specialized in drug delivery... 
by FiveSenses | Sep 15, 2025 | News Release
Montreal, QC, Canada, September 15th, 2025 – Defence Therapeutics Inc. (“Defence” or the “Company”), a leading biotechnology company specialized in drug delivery technologies, is pleased to announce the closing of its previously announced non-brokered private... 
by FiveSenses | Sep 2, 2025 | News Release
Montreal, QC, Canada, September 2nd, 2025 – Defence Therapeutics Inc. (“Defence” or the “Company”), a leading biotechnology company specialized in drug delivery technologies, is pleased to announce the engagement of Amie Phinney, PhD, MBA as the Strategy &...
Recent Comments